Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Leukemia

Free Subscription Articles published in Eur J Haematol Retrieve available abstracts of 65 articles: HTML format Text format

Single Articles

January 2012
1. LI X , Cen J, Wang Q, Dong S, et al
   Absence of DNMT3A gene mutation in chronic myeloid leukemia patients in blast crisis.
   Eur J Haematol. 2012 Jan 17. doi: 10.1111/j.1600-0609.2012.01755.
   PubMed     Text format     Related articles   
   
   
   
   
2. BOHME A , Atta J, Mousset S, Ehlken B, et al
   Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital.
   Eur J Haematol. 2012;88:68-77.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. LEVINSEN M , Shabaneh D, Bohnstedt C, Harila-Saari A, et al
   Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia.
   Eur J Haematol. 2012;88:78-86.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
4. CHANG H , Kuo MC, Shih LY, Dunn P, et al
   Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
   Eur J Haematol. 2011 Dec 30. doi: 10.1111/j.1600-0609.2011.01747.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
5. ISMAIL EA , Mahmoud HM, Tawfik LM, Habashy DM, et al
   BIRC6/Apollon Gene Expression in Childhood Acute Leukemia: Impact on Therapeutic Response and Prognosis.
   Eur J Haematol. 2011 Nov 15. doi: 10.1111/j.1600-0609.2011.01734.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. CHOW KU , Kim SZ, von Neuhoff N, Schlegelberger B, et al
   Clinical efficacy of immunochemotherapy with fludarabine, epirubicin and rituximab in the treatment for chronic lymphocytic leukaemia and prolymphocytic leukaemia.
   Eur J Haematol. 2011;87:426-33.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. KRISTENSEN T , Moller MB, Friis L, Bergmann OJ, et al
   NPM1 mutation is a stable marker for minimal residual disease monitoring in acute myeloid leukaemia patients with increased sensitivity compared to WT1 expression.
   Eur J Haematol. 2011;87:400-8.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. ROUG AS , Nyvold CG, Juhl-Christensen C, Christensen M, et al
   A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.
   Eur J Haematol. 2011;87:461-3.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
9. ELLIOTT MA , Letendre L, Tefferi A, Hogan WJ, et al
   Therapy-related acute promyelocytic leukemia (t-APL): Observations relating to APL pathogenesis and therapy.
   Eur J Haematol. 2011 Oct 24. doi: 10.1111/j.1600-0609.2011.01727.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. MARKOVA J , Michkova P, Burckova K, Brezinova J, et al
    Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia.
    Eur J Haematol. 2011 Oct 4. doi: 10.1111/j.1600-0609.2011.01716.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. ARUMAINATHAN A , Kalakonda N, Pettitt AR
    Lenalidomide can be highly effective in chronic lymphocytic leukaemia despite T-cell depletion and deletion of chromosome 17p.
    Eur J Haematol. 2011;87:372-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
12. SHARMA M , Dayama A, Jain S, Saxena R, et al
    AML associated with extensive erythrophagocytosis and tetraploidy.
    Eur J Haematol. 2011;87:286.
    PubMed     Text format     Related articles   
    
    
    
    August 2011
13. BUCHHOLZ S , Dammann E, Stadler M, Krauter J, et al
    Cytoreductive treatment with Clofarabine / Ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.
    Eur J Haematol. 2011 Aug 31. doi: 10.1111/j.1600-0609.2011.01703.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. ZHENG J , Chen S, Jiang L, You Y, et al
    Functional Genetic Variations of Cyclooxygenase-2 and Susceptibility to Acute Myeloid Leukemia in a Chinese Population.
    Eur J Haematol. 2011 Aug 17. doi: 10.1111/j.1600-0609.2011.01691.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. VAIDYA S , Ghosh K, Vundinti BR
    Recent developments in drug resistance mechanism in chronic myeloid leukemia: A review.
    Eur J Haematol. 2011 Aug 4. doi: 10.1111/j.1600-0609.2011.01689.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. MARTIN-PALANCO V , Martinez F, Arqueros V, Torres A, et al
    Long-term durability of molecular and chimerism responses in patients treated with imatinib for chronic myeloid leukemia relapse after allogeneic transplantation.
    Eur J Haematol. 2011;87:182-5.
    PubMed     Text format     Related articles   
    
    
    
    
17. LARFORS G , Hoglund M, Cnattingius S
    Pregnancy and risk of acute myeloid leukaemia--a case-control study.
    Eur J Haematol. 2011;87:169-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. BAUMANN FT , Zopf EM, Nykamp E, Kraut L, et al
    Physical activity for patients undergoing an allogeneic hematopoietic stem cell transplantation: benefits of a moderate exercise intervention.
    Eur J Haematol. 2011;87:148-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
19. HUANG JZ , Folbe MH, Richard SR, Kloins MK, et al
    Chronic lymphocytic leukemia with nuclear budding.
    Eur J Haematol. 2011 Jul 29. doi: 10.1111/j.1600-0609.2011.01688.
    PubMed     Text format     Related articles   
    
    
    
    
20. JANSSEN A , van der Bruggen T, Haas PJ, de Jong PA, et al
    Comparison of the occurrence of mould infection among patients receiving chemotherapy for acute leukemia versus patients undergoing stem cell transplantation.
    Eur J Haematol. 2011 Jul 6. doi: 10.1111/j.1600-0609.2011.01678.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. JIMENEZ-ZEPEDA VH , Neme-Yunes Y, Braggio E
    Chromosome abnormalities defined by conventional cytogenetics in plasma cell leukemia: what have we learned about its biology?
    Eur J Haematol. 2011;87:20-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. GONZALEZ-VICENT M , Molina B, Andion M, Sevilla J, et al
    Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study.
    Eur J Haematol. 2011;87:46-53.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. AYDIN S , Grabellus F, Eisele L, Mollmann M, et al
    Investigating the role of CD38 and functionally related molecular risk factors in the CLL NOD/SCID xenograft model.
    Eur J Haematol. 2011;87:10-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
24. SMEETA G , Gupta R, Sharma A, Gupta R, et al
    Acute Myeloid Leukemia with Pseudo-Chediak Higashi Granules and Intracytoplasmic Vacuoles.
    Eur J Haematol. 2011 Jun 16. doi: 10.1111/j.1600-0609.2011.01668.
    PubMed     Text format     Related articles   
    
    
    
    
25. NOVITZKY-BASSO I , Craddock C
    Cross-intolerance to imatinib, dasatinib and nilotinib therapy in a patient with chronic myeloid leukaemia.
    Eur J Haematol. 2011;86:548-9.
    PubMed     Text format     Related articles   
    
    
    
    May 2011
26. LEE JH , Lee JH, Kim DY, Yun SC, et al
    Pre-engraftment graft-versus-host disease after allogeneic hematopoietic cell transplantation for acute leukemia.
    Eur J Haematol. 2011 May 23. doi: 10.1111/j.1600-0609.2011.01646.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. CRISTINA T , Ilaria N, Federico M, Francesca Z, et al
    APRIL (A PROLIFERATION-INDUCING LIGAND) SERUM LEVELS PREDICT TIME TO FIRST TREATMENT IN PATIENTS AFFECTED BY B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA.
    Eur J Haematol. 2011 May 19. doi: 10.1111/j.1600-0609.2011.01650.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KIM MS , Chung NG, Yoo NJ, Lee SH, et al
    Somatic mutation of proapoptotic caspase-2 gene is rare in acute leukemias and common solid cancers.
    Eur J Haematol. 2011;86:449-50.
    PubMed     Text format     Related articles   
    
    
    
    April 2011
29. DOUBEK M , Mayer J, Obrtlikova P, Smolej L, et al
    Modern and conventional prognostic markers of chronic lymphocytic leukemia (CLL) in the everyday hematological practice.
    Eur J Haematol. 2011 Apr 29. doi: 10.1111/j.1600-0609.2011.01639.
    PubMed     Text format     Related articles   
    
    
    
    
30. FABER E , Muzik J, Koza V, Demeckova E, et al
    Treatment of consecutive patients with chronic myeloid leukemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 - a report from the population-based CAMELIA Registry.
    Eur J Haematol. 2011 Apr 28. doi: 10.1111/j.1600-0609.2011.01637.
    PubMed     Text format     Related articles   
    
    
    
    
31. ARN KD , Dazzi H, Went P, Goede JS, et al
    Erythroleukaemia at second glance.
    Eur J Haematol. 2011;86:358-9.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
32. ROMINA NP , Mercedes B, Carla MV, Cecilia A, et al
    CCR4 expression in a case of cutaneous Richter's transformation of chronic lymphocytic leukaemia (CLL) to diffuse large B cell lymphoma (DLBCL) and in CLL patients with no skin manifestations.
    Eur J Haematol. 2011 Mar 28. doi: 10.1111/j.1600-0609.2011.01613.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. BORST L , Wallerek S, Dalhoff K, Rasmussen KK, et al
    The impact of CYP3A5*3 on risk and prognosis in childhood acute lymphoblastic leukemia.
    Eur J Haematol. 2011 Mar 19. doi: 10.1111/j.1600-0609.2011.01608.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. MITAL A , Piskorz A, Lewandowski K, Wasag B, et al
    A case of mast cell leukemia with exon 9 KIT mutation and good response to imatinib.
    Eur J Haematol. 2011 Mar 1. doi: 10.1111/j.1600-0609.2011.01598.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. HSIEH YY , Hong YC, Hsiao LT, Yu YB, et al
    Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.
    Eur J Haematol. 2011;86:237-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. KATSUMI A , Kiyoi H, Abe A, Tanizaki R, et al
    FLT3/ ITD regulates leukaemia cell adhesion through alpha4beta1 integrin and Pyk2 signalling.
    Eur J Haematol. 2011;86:191-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
37. QIAO C , Zhang SJ, Chen LJ, Miao KR, et al
    Identification of the STAT5B-RARalpha fusion transcript in an acute promyelocytic leukemia patient without FLT3, NPM1, c-Kit and C/EBPalpha mutation.
    Eur J Haematol. 2011 Feb 24. doi: 10.1111/j.1600-0609.2011.01595.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. RADUJKOVIC A , Bellos F, Andrulis M, Ho AD, et al
    Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemia.
    Eur J Haematol. 2011 Feb 22. doi: 10.1111/j.1600-0609.2011.01594.
    PubMed     Text format     Related articles   
    
    
    
    
39. BUHL AM , James DF, Neuberg D, Jain S, et al
    Analysis of CLLU1 expression levels before and after therapy in patients with Chronic Lymphocytic Leukemia.
    Eur J Haematol. 2011 Feb 15. doi: 10.1111/j.1600-0609.2011.01588.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. ABDULKARIM K , Ridell B, Johansson P, Kutti J, et al
    The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
    Eur J Haematol. 2011;86:148-55.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
41. HEMMATI PG , Terwey TH, le Coutre P, Vuong LG, et al
    A modified EBMT risk score predicts the outcome of patients with acute myeloid leukemia receiving allogeneic stem cell transplants.
    Eur J Haematol. 2011 Jan 25. doi: 10.1111/j.1600-0609.2011.01580.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
42. CHANG H , Liaw CC, Chang HK
    Earlier and Commoner: Therapy Related Leukemia after Concurrent Chemoradiotherapy for Esophageal cancer.
    Eur J Haematol. 2011 Jan 12. doi: 10.1111/j.1600-0609.2011.01577.
    PubMed     Text format     Related articles   
    
    
    
    
43. GIALLONGO C , La Cava P, Tibullo D, Parrinello N, et al
    Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of Chronic Myeloid Leukemia cells.
    Eur J Haematol. 2011 Jan 2. doi: 10.1111/j.1600-0609.2010.01570.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. VAITKEVICIENE G , Forestier E, Hellebostad M, Heyman M, et al
    High white blood cell count at diagnosis of childhood acute lymphoblastic leukaemia: biological background and prognostic impact. Results from the NOPHO ALL-92 and ALL-2000 studies.
    Eur J Haematol. 2011;86:38-46.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
45. JIANG L , Liang J, Jiang M, Yu X, et al
    Functional Polymorphisms in the NBS1 gene and acute lymphoblastic leukemia susceptibility in a Chinese population.
    Eur J Haematol. 2010 Dec 17. doi: 10.1111/j.1600-0609.2010.01562.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. TASHIRO H , Shirasaki R, Oka Y, Sugao T, et al
    FLT3 internal tandem duplication is associated with a high relapse rate and central nervous system involvement in acute promyelocytic leukemia cases: single institutional analysis.
    Eur J Haematol. 2010 Dec 3. doi: 10.1111/j.1600-0609.2010.01559.
    PubMed     Text format     Related articles   
    
    
    
    
47. SADA E , Abe Y, Ohba R, Tachikawa Y, et al
    Vitamin K2 modulates differentiation and apoptosis of both myeloid and erythroid lineages.
    Eur J Haematol. 2010;85:538-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
48. LANGABEER SE , Owen CJ, McCarron SL, Fitzgibbon J, et al
    A novel RUNX1 mutation in a kindred with familial platelet disorder with propensity to acute myeloid leukaemia: male predominance of affected individuals.
    Eur J Haematol. 2010;85:552-3.
    PubMed     Text format     Related articles   
    
    
    
    November 2010
49. ALI D , Jonsson-Videsater K, Deneberg S, Bengtzen S, et al
    APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.
    Eur J Haematol. 2010 Nov 28. doi: 10.1111/j.1600-0609.2010.01557.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. UEKI T , Sumi M, Sato K, Shimizu I, et al
    Reduced-intensity cord blood transplantation without prior remission induction therapy induces durable remission in adult patients with relapsed acute leukemia after the first allogeneic transplantation.
    Eur J Haematol. 2010 Nov 26. doi: 10.1111/j.1600-0609.2010.01555.
    PubMed     Text format     Related articles   
    
    
    
    
51. SELLNER L , Capper D, Meyer J, Langhans CD, et al
    Increased levels of 2-hydroxyglutarate in AML patients with IDH1-R132H and IDH2-R140Q mutations.
    Eur J Haematol. 2010;85:457-9.
    PubMed     Text format     Related articles   
    
    
    
    
52. OLSSON-STROMBERG U , Hermansson M, Lundan T, Ohm AC, et al
    Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib.
    Eur J Haematol. 2010;85:399-404.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
53. OJI Y , Oka Y, Nishida S, Tsuboi A, et al
    WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient.
    Eur J Haematol. 2010;85:358-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. HAMALAINEN M , Juvonen V, Haikio S, Lakkala T, et al
    ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status.
    Eur J Haematol. 2010;85:361-2.
    PubMed     Text format     Related articles   
    
    
    
    September 2010
55. D'ARENA G , Capalbo S, Laurenti L, Del Poeta G, et al
    CHRONIC LYMPHOCYTIC LEUKEMIA-ASSOCIATED IMMUNE THROMBOCYTOPENIA TREATED WITH RITUXIMAB: A RETROSPECTIVE STUDY OF 21 PATIENTS.
    Eur J Haematol. 2010 Sep 16. doi: 10.1111/j.1600-0609.2010.01527.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
56. OSTGARD LS , Kjeldsen E, Holm MS, Brown Pde N, et al
    Reasons for treating secondary AML as de novo AML.
    Eur J Haematol. 2010;85:217-26.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
57. LAN Q , Au WY, Chanock S, Tse J, et al
    Genetic susceptibility for chronic lymphocytic leukemia among Chinese in Hong Kong.
    Eur J Haematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. SUN W , Yang S, Shen W, Li H, et al
    Identification of DeltaEF1 as a novel target that negatively regulated by LMO2 in T cell leukemia.
    Eur J Haematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. GIEHL M , Leitner A, Haferlach C, Duesberg P, et al
    Detection of centrosome aberrations in disease-unrelated cells from patients with tumor treated with tyrosine kinase inhibitors.
    Eur J Haematol. 2010;85:139-48.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. CRO L , Ferrario A, Lionetti M, Bertoni F, et al
    The clinical and biological features of a series of immunophenotypic variant of B-CLL.
    Eur J Haematol. 2010;85:120-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
61. PRZYBYLSKI GK , Dittmann K, Grabarczyk P, Dolken G, et al
    Molecular characterization of a novel chromosomal translocation t(12;14)(q23;q11.2) in T-lymphoblastic lymphoma between the T cell receptor delta deleting elements (TRDREC and TRAJ61) and the hypothetical gene C12orf42.
    Eur J Haematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
62. ROHON P , Porkka K, Mustjoki S
    Immunoprofiling of chronic myeloid leukemia patients at diagnosis and during tyrosine kinase inhibitor therapy.
    Eur J Haematol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. CHAKER L , Segeren CM, Bot FJ, Maartense E, et al
    Haemophagocytic syndrome and Hodgkin's disease variant of Richter's syndrome after fludarabine for CLL.
    Eur J Haematol. 2010;85:91-2.
    PubMed     Text format     Related articles   
    
    
    
    
64. KLOSTERGAARD A , Steffensen R, Moller JK, Peterslund N, et al
    Sepsis in acute myeloid leukaemia patients receiving high-dose chemotherapy: no impact of chitotriosidase and mannose-binding lectin polymorphisms.
    Eur J Haematol. 2010;85:58-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
65. FORGHIERI F , Potenza L, Morselli M, Maccaferri M, et al
    Organising pneumonia mimicking invasive fungal disease in patients with leukaemia.
    Eur J Haematol. 2010;85:76-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: